According to Ocuphire Pharma's latest financial reports the company's current revenue (TTM) is $19.04 M. In 2022 the company made a revenue of $39.85 M an increase over the years 2021 revenue that were of $0.58 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $19.04 M | -52.2% |
2022 | $39.85 M | 6665.7% |
2021 | $0.58 M | |
2020 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 4,433.01% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -98.81% | ๐บ๐ธ USA |